Speaker
Gregory Charville, MD, PhD, Stanford University School of Medicine
At the conclusion of this activity, learners should be able to:
* Describe the biological and diagnostic significance of recurrent gene fusions in bone and soft tissue tumors
* Identify recurrent genetic abnormalities associated with myxoid liposarcoma, alveolar rhabdomyosarcoma, and dermatofibrosarcoma protuberans
* Discuss the benefits and costs of using histological biomarkers as surrogates of pathogenic gene fusions
Event Series
Current Topics in Pathology 2023